Lion: Ping An Good Doctor (01833.HK) is the main beneficiary of AI healthcare in China, with a target price raised to HK$20 and a reiterated "outperform" rating.

Zhitong Finance APP learned that Lyon released a research report stating that Ping An Good Doctor (01833.HK) achieved remarkable performance in the first half of this year, with revenue increasing by 19.5% year-on-year to 2.5 billion yuan, and adjusted net profit increasing significantly by 136.8% year-on-year to 134 million yuan. Lyon believes that the strong performance of Ping An Good Doctor's stock price can be attributed to its progress in medical AI and improved profit prospects. The vigorous development of AI medical empowerment and commercial health insurance is expected to further drive its growth, so Lyon raised its target price from 10 Hong Kong dollars to 20 Hong Kong dollars based on cash flow discount rate, and reiterated its "outperform market" rating.